Last reviewed · How we verify
Capecitabine oral administration — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Capecitabine oral administration (Capecitabine oral administration) — Akamis Bio.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Capecitabine oral administration TARGET | Capecitabine oral administration | Akamis Bio | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Capecitabine oral administration CI watch — RSS
- Capecitabine oral administration CI watch — Atom
- Capecitabine oral administration CI watch — JSON
- Capecitabine oral administration alone — RSS
Cite this brief
Drug Landscape (2026). Capecitabine oral administration — Competitive Intelligence Brief. https://druglandscape.com/ci/capecitabine-oral-administration. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab